Transmedics Group Stock Operating Margin

TMDX Stock

USD 64.26 1.45 2.21%

TransMedics Group fundamentals help investors to digest information that contributes to TransMedics' financial success or failures. It also enables traders to predict the movement of TransMedics Stock. The fundamental analysis module provides a way to measure TransMedics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to TransMedics stock.

		Last Reported	Projected for Next Year
	Operating Profit Margin	(0.12)	(0.12)

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

TransMedics Group Company Operating Margin Analysis

TransMedics' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

Operating Income

Revenue

100

More About Operating Margin | All Equity Analysis

Current TransMedics Operating Margin

0.04 %

Most of TransMedics' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, TransMedics Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

TransMedics Operating Margin Driver Correlations

Understanding the fundamental principles of building solid financial models for TransMedics is extremely important. It helps to project a fair market value of TransMedics Stock properly, considering its historical fundamentals such as Operating Margin. Since TransMedics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of TransMedics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of TransMedics' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Net Receivables	Current Deferred Revenue	Net Debt	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Short Long Term Debt	Net Working Capital	Short Term Debt	Deferred Long Term Liab	Capital Stock	Intangible Assets
Total Assets		0.7	0.81	-0.75	0.86	0.98	-0.37	0.94	1.0	0.61	0.91	0.99	0.96	0.64	0.59	0.94	0.96	-0.91	0.99	0.14	-0.62	0.78	-0.91
Total Stockholder Equity	0.7		0.93	-0.74	0.47	0.59	-0.08	0.53	0.73	0.96	0.83	0.7	0.52	0.16	0.94	0.52	0.86	-0.49	0.77	0.62	-0.91	0.92	-0.49
Net Tangible Assets	0.81	0.93		-0.75	0.58	0.71	-0.05	0.66	0.85	0.86	0.89	0.81	0.65	0.27	0.8	0.65	0.9	-0.62	0.87	0.4	-0.92	0.95	-0.62
Retained Earnings	-0.75	-0.74	-0.75		-0.69	-0.66	0.01	-0.66	-0.78	-0.79	-0.82	-0.73	-0.6	-0.27	-0.77	-0.59	-0.82	0.58	-0.77	-0.45	0.77	-0.82	0.58
Accounts Payable	0.86	0.47	0.58	-0.69		0.9	-0.32	0.87	0.84	0.44	0.75	0.85	0.88	0.75	0.5	0.87	0.81	-0.85	0.81	0.2	-0.47	0.53	-0.85
Long Term Debt	0.98	0.59	0.71	-0.66	0.9		-0.42	0.97	0.96	0.49	0.83	0.97	1.0	0.77	0.52	0.97	0.91	-0.95	0.95	0.11	-0.5	0.66	-0.95
Short Term Investments	-0.37	-0.08	-0.05	0.01	-0.32	-0.42		-0.46	-0.34	0.02	-0.39	-0.45	-0.44	-0.14	0.03	-0.42	-0.28	0.41	-0.34	0.4	-0.21	-0.13	0.41
Total Liab	0.94	0.53	0.66	-0.66	0.87	0.97	-0.46		0.92	0.45	0.81	0.94	0.97	0.74	0.47	0.94	0.87	-0.92	0.92	0.07	-0.47	0.63	-0.92
Total Current Assets	1.0	0.73	0.85	-0.78	0.84	0.96	-0.34	0.92		0.65	0.93	0.99	0.93	0.59	0.63	0.91	0.96	-0.89	1.0	0.16	-0.67	0.83	-0.89
Common Stock	0.61	0.96	0.86	-0.79	0.44	0.49	0.02	0.45	0.65		0.77	0.6	0.42	0.08	0.97	0.46	0.79	-0.33	0.68	0.68	-0.93	0.91	-0.33
Property Plant Equipment	0.91	0.83	0.89	-0.82	0.75	0.83	-0.39	0.81	0.93	0.77		0.92	0.79	0.33	0.71	0.77	0.93	-0.75	0.94	0.21	-0.74	0.92	-0.75
Net Receivables	0.99	0.7	0.81	-0.73	0.85	0.97	-0.45	0.94	0.99	0.6	0.92		0.95	0.61	0.59	0.93	0.95	-0.91	0.99	0.11	-0.6	0.79	-0.91
Current Deferred Revenue	0.96	0.52	0.65	-0.6	0.88	1.0	-0.44	0.97	0.93	0.42	0.79	0.95		0.8	0.45	0.97	0.87	-0.95	0.92	0.06	-0.43	0.59	-0.95
Net Debt	0.64	0.16	0.27	-0.27	0.75	0.77	-0.14	0.74	0.59	0.08	0.33	0.61	0.8		0.21	0.78	0.56	-0.76	0.57	0.16	-0.15	0.12	-0.76
Long Term Debt Total	0.59	0.94	0.8	-0.77	0.5	0.52	0.03	0.47	0.63	0.97	0.71	0.59	0.45	0.21		0.47	0.8	-0.38	0.66	0.8	-0.88	0.81	-0.38
Capital Surpluse	0.94	0.52	0.65	-0.59	0.87	0.97	-0.42	0.94	0.91	0.46	0.77	0.93	0.97	0.78	0.47		0.86	-0.85	0.9	0.05	-0.47	0.62	-0.85
Net Invested Capital	0.96	0.86	0.9	-0.82	0.81	0.91	-0.28	0.87	0.96	0.79	0.93	0.95	0.87	0.56	0.8	0.86		-0.83	0.97	0.4	-0.77	0.87	-0.83
Short Long Term Debt	-0.91	-0.49	-0.62	0.58	-0.85	-0.95	0.41	-0.92	-0.89	-0.33	-0.75	-0.91	-0.95	-0.76	-0.38	-0.85	-0.83		-0.88	-0.06	0.38	-0.52	1.0
Net Working Capital	0.99	0.77	0.87	-0.77	0.81	0.95	-0.34	0.92	1.0	0.68	0.94	0.99	0.92	0.57	0.66	0.9	0.97	-0.88		0.19	-0.69	0.85	-0.88
Short Term Debt	0.14	0.62	0.4	-0.45	0.2	0.11	0.4	0.07	0.16	0.68	0.21	0.11	0.06	0.16	0.8	0.05	0.4	-0.06	0.19		-0.63	0.35	-0.06
Deferred Long Term Liab	-0.62	-0.91	-0.92	0.77	-0.47	-0.5	-0.21	-0.47	-0.67	-0.93	-0.74	-0.6	-0.43	-0.15	-0.88	-0.47	-0.77	0.38	-0.69	-0.63		-0.9	0.38
Capital Stock	0.78	0.92	0.95	-0.82	0.53	0.66	-0.13	0.63	0.83	0.91	0.92	0.79	0.59	0.12	0.81	0.62	0.87	-0.52	0.85	0.35	-0.9		-0.52
Intangible Assets	-0.91	-0.49	-0.62	0.58	-0.85	-0.95	0.41	-0.92	-0.89	-0.33	-0.75	-0.91	-0.95	-0.76	-0.38	-0.85	-0.83	1.0	-0.88	-0.06	0.38	-0.52

Click cells to compare fundamentals

A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.

Competition

Predict TransMedics

Operating Profit Margin Over Time

TransMedics Pretax Profit Margin

Pretax Profit Margin

(0.12)

At this time, TransMedics' Pretax Profit Margin is fairly stable compared to the past year.

Based on the recorded statements, TransMedics Group has an Operating Margin of 0.0361%. This is 100.1% lower than that of the Health Care Equipment & Supplies sector and 100.09% lower than that of the Health Care industry. The operating margin for all United States stocks is 100.66% lower than that of the firm.

TransMedics Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses TransMedics' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of TransMedics could also be used in its relative valuation, which is a method of valuing TransMedics by comparing valuation metrics of similar companies.

TransMedics is currently under evaluation in operating margin category among its peers.

TransMedics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, TransMedics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to TransMedics' managers, analysts, and investors.

Environmental

Governance

Social

TransMedics Fundamentals

	Return On Equity	0.19
	Return On Asset	0.0284
	Profit Margin	0.08 %
	Operating Margin	0.04 %
	Current Valuation	2.34 B
	Shares Outstanding	33.56 M
	Shares Owned By Insiders	3.21 %
	Shares Owned By Institutions	96.79 %
	Number Of Shares Shorted	9.29 M
	Price To Book	10.27 X
	Price To Sales	5.38 X
	Revenue	241.62 M
	Gross Profit	65.27 M
	EBITDA	(7.6 M)
	Net Income	(25.03 M)
	Cash And Equivalents	204.46 M
	Cash Per Share	6.41 X
	Total Debt	515.95 M
	Debt To Equity	0.36 %
	Current Ratio	12.11 X
	Book Value Per Share	6.25 X
	Cash Flow From Operations	(13.03 M)
	Short Ratio	4.14 X
	Earnings Per Share	0.93 X
	Target Price	107.86
	Number Of Employees	584
	Beta	2.07
	Market Capitalization	2.16 B
	Total Asset	706.05 M
	Retained Earnings	(503.7 M)
	Working Capital	455.72 M
	Net Asset	706.05 M

About TransMedics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze TransMedics Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TransMedics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TransMedics Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for TransMedics Stock Analysis

When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC